间歇正压通气联合肺表面活性物质治疗新生儿呼吸窘迫综合征疗效及有效率分析

doi:10.3969/j.issn.1001-8131.2023.06.014

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (420 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate and analyze the therapeutic effect of nasal synchronous positive intermittent pressure ventilation（NSIPPV）combined with pulmonary surfactant（PS）on neonates with respiratory distress syndrome（NRDS）. Methods 96 neonates with NRDS who were treatedwere randomly divided into two groups by computer numerical table.The control group was treated with NSIPPV, and the observation group was treated with PS on this basis.The clinical efficacy and complications, blood gas analysis indexes before and after treatment and various treatment indexes of the two groups were compared. Results The effective rate of the observation group was 93.75%, which was significantly higher than that of the control group（77.08%, P< 0.05）; The incidence of complications such as pulmonary hemorrhage, ventilator-associated pneumonia, pneumothorax, arrhythmia and retinopathy in the observation group was significantly lower than that in the control group（P< 0.05）; After treatment, PaO₂, SaO₂ and OI in the observation group were higher than those in the control group, while PaCO2 was lower than that in the control group（P< 0.05）; The time of oxygen therapy, the time of symptom disappearance, the time of hospitalization and the rate of tracheal intubation in the observation group were less than those in the control group（P< 0.05）. Conclusion The therapeutic effect of NSIPPV combined with PS on NRDS neonates is significant, which can effectively improve the blood gas analysis indicators, speed up the remission of the disease, reduce the rate of tracheal intubation and complications, and help improve the prognosis.It has important clinical significance.

Key words： NRDS NSIPPV PS Efficacy Blood gas complication

Received: 10 December 2022

PACS:

R725.6

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Chen Tiantian

Cite this article:

Chen Tiantian. Analysis of the Efficacy and Efficiency of Intermittent Positive Pressure Ventilation Combined with Pulmonary Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome[J]. journal1, 2023, 43(6): 38-40.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2023.06.014 OR http://www.hrbyybjb.org.cn/EN/Y2023/V43/I6/38

[1] 王宋青, 闻建军, 施益农.经鼻间歇正压通气治疗新生儿呼吸窘迫综合征的临床研究[J].临床肺科杂志, 2016, 21(12):2219-2222.
[2] 李菲, 唐萍.经鼻间歇正压通气联合大剂量牛肺表面活性剂治疗重症新生儿呼吸窘迫综合征的疗效[J].实用临床医药杂志, 2020, 24(14):71-75.
[3] 阿不都尼比·阿不都吉力力.经鼻间歇正压通气治疗新生儿呼吸窘迫综合征对患儿血气指标及血清 TGF-β1、BMP-7 水平的影响[J].现代医学与健康研究, 2020, 4(22):14-16.
[4] 张靖, 张焕新, 王景.不同剂量牛肺表面活性剂联合经鼻间歇正压通气治疗新生儿呼吸窘迫综合征的临床观察[J].中国药房, 2016, 27(35):4985-4987.
[5] DAVID G SWEET, VIRGILIO CARNIELLI, GORM GREISEN, 等.欧洲新生儿呼吸窘迫综合征防治共识指南:2017 版[J].中华儿科杂志, 2017, 55(3):33-39.
[6] 余刚, 王昕.双水平正压通气支持与经鼻间歇正压通气对呼吸窘迫综合征新生儿呼吸力学和氧化应激反应的影响[J].陕西医学杂志, 2022, 51(7):856-859.
[7] 朱道谋, 钟丽花, 陈彩华.间歇正压通气联合肺表面活性物质治疗新生儿呼吸窘迫综合征疗效[J].河北医学, 2021, 27(5):850-855.
[8] 杨云莲, 张鹏, 郭平佳.无创正压通气联合肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效及对患儿血气指标的影响[J].中国妇幼保健, 2021, 36(11):2553-2555.
[9] 刘英战, 博海平.经细导管注入牛肺表面活性物质联合双相呼吸道正压通气治疗新生儿呼吸窘迫综合征的疗效及安全性[J].儿科药学杂志, 2019, 25(8):28-31.
[10] 陈春明, 关健强, 麦纪红.经鼻间歇正压通气辅助呼吸治疗新生儿呼吸窘迫综合征疗效观察[J].海南医学, 2021, 32(8):999-1002.
[11] 张慧, 李锋, 张树清.鼻腔持续与间歇正压通气联合肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效[J].儿科药学杂志, 2020, 26(9):28-31.
[12] 袁艳冰, 刘海燕.经鼻间歇正压通气与经鼻持续正压通气治疗早产儿合并新生儿呼吸窘迫综合征的安全性及有效性分析[J].吉林医学, 2020, 41(11):2629-2631.
[13] 罗立倩, 何阿玲, 杨冬, 等.微创肺表面活性物质给药+布地奈德+同步鼻塞间歇正压通气治疗新生儿呼吸窘迫综合征的效果及对炎性因子、通气状态的影响[J].临床医学研究与实践, 2022, 7(23):95-98, 130.
[14] 李菲, 刘小亮.持续正压通气联合肺表面活性物质治疗呼吸窘迫综合征效果及对新生儿安全性临床研究[J].陕西医学杂志, 2019, 48(1):52-54.
[15] 程可萍, 方程钰, 胡晓慧, 等.经鼻同步间歇正压通气治疗新生儿呼吸窘迫综合征的疗效及对患儿PcO₂和PcCO₂的影响[J].中国妇幼保健, 2020, 35(16):3007-3010.